NCT07057713
Total Arterial vs. Mixed Grafting in Left Coronary CABG
At risk: Primary completion moved 12 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Aug 1, 2027 to Aug 1, 2028 Show 4 more changesShow less
- Start date: Aug 1, 2026 to Aug 1, 2027
- Eligibility criteria expanded, about 13 words
- Study completion pushed from Dec 30, 2027 to Dec 30, 2028
- Secondary endpoints: details revised at 2 of 2 entries
- Notable Primary completion date: Aug 1, 2026 to Aug 1, 2027
- Start date: Aug 1, 2025 to Aug 1, 2026
- Study completion date: Dec 30, 2026 to Dec 30, 2027
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (2)
Arms and interventions
Patients in this group will undergo coronary artery bypass grafting (CABG) with total arterial grafts to the left coronary artery system. The left internal thoracic artery (LITA) will be grafted to the left anterior descending artery (LAD), and the radial artery will be anastomosed to the obtuse marginal or diagonal branches of the circumflex artery. The right coronary artery, if revascularized, will receive a conventional vein graft.
Patients in this group will receive conventional mixed grafting during CABG. The left internal thoracic artery (LITA) will be used for the LAD, while the great saphenous vein will be grafted to other branches of the left coronary artery system, such as the obtuse marginal or diagonal branches. The right coronary artery, if revascularized, will also be grafted using a vein.
Procedures: Total Arterial Grafting, Conventional Mixed Grafting
Sites
1 site in 1 country
- The Second Hospital of Jilin UniversityChangchun, Jilin, China